Literature DB >> 26053588

Health disparities in liver disease in sub-Saharan Africa.

C Wendy Spearman1, Mark W Sonderup1.   

Abstract

Disparities in health reflect the differences in the incidence, prevalence, burden of disease and access to care determined by socio-economic and environmental factors. With liver disease, these disparities are exacerbated by a combination of limited awareness and preventable causes of morbidity and mortality in addition to the diagnostic and management costs. Sub-Saharan Africa, comprising 11% of the world's population, disproportionately has 24% of the global disease burden, yet allocates <1% of global spend on health. It has 3% of the global healthcare workforce with a mean of 0.8 healthcare workers per 1000 population. Barriers to healthcare access are many and compounded by limited civil registration data, socio-economic inequalities, discrepancies in private and public healthcare services and geopolitical strife. The UN 2014 report on the Millennium Development Goals suggest that sub-Saharan Africa will probably not meet several goals, however with HIV/AIDS and Malaria (goal 6), many successes have been achieved. A 2010 Global Burden of Disease study demonstrated that cirrhosis mortality in sub-Saharan Africa doubled between 1980 and 2010. Aetiologies included hepatitis B (34%), hepatitis C (17%), alcohol (18%) and unknown in 31%. Hepatitis B, C and alcohol accounted for 47, 23 and 20% of hepatocellular carcinoma respectively. In 10%, the underlying aetiology was not known. Liver disease reflects the broader disparities in healthcare in sub-Saharan Africa. However, many of these challenges are not insurmountable as vaccines and new therapies could comprehensively deal with the burden of viral hepatitis. Access to and affordability of therapeutics remains the major barrier.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  health disparities; liver disease; sub-Saharan Africa

Mesh:

Year:  2015        PMID: 26053588     DOI: 10.1111/liv.12884

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  13 in total

Review 1.  Disease Burden of Hepatocellular Carcinoma: A Global Perspective.

Authors:  Mehmet Sayiner; Pegah Golabi; Zobair M Younossi
Journal:  Dig Dis Sci       Date:  2019-04       Impact factor: 3.199

2.  Liver steatosis and metabolic dysfunction-associated fatty liver disease among HIV-positive and negative adults in urban Zambia.

Authors:  Belinda Varaidzo Chihota; Carlotta Riebensahm; Guy Muula; Edford Sinkala; Roma Chilengi; Lloyd Mulenga; Samuel Bosomprah; Michael J Vinikoor; Carolyn Bolton-Moore; Matthias Egger; Andri Rauch; Annalisa Berzigotti; Gilles Wandeler
Journal:  BMJ Open Gastroenterol       Date:  2022-07

3.  Paracetamol clinical dosing routine leads to paracetamol underexposure in an adult severely ill sub-Saharan African hospital population: a drug concentration measurement study.

Authors:  Jeannet C Bos; Mabor C Mistício; Ginto Nunguiane; Ron A A Mathôt; Reinier M van Hest; Jan M Prins
Journal:  BMC Res Notes       Date:  2017-12-04

4.  High Prevalence and Diversity of Hepatitis Viruses in Suspected Cases of Yellow Fever in the Democratic Republic of Congo.

Authors:  Sheila Makiala-Mandanda; Frédéric Le Gal; Nadine Ngwaka-Matsung; Steve Ahuka-Mundeke; Richard Onanga; Berthold Bivigou-Mboumba; Elisabeth Pukuta-Simbu; Athenaïs Gerber; Jessica L Abbate; Dieudonné Mwamba; Nicolas Berthet; Eric Maurice Leroy; Jean-Jacques Muyembe-Tamfum; Pierre Becquart
Journal:  J Clin Microbiol       Date:  2017-02-15       Impact factor: 5.948

Review 5.  Trends in hepatitis B virus testing practices and management in HIV clinics across sub-Saharan Africa.

Authors:  Patrick A Coffie; Matthias Egger; Michael J Vinikoor; Marcel Zannou; Lameck Diero; Akouda Patassi; Mark H Kuniholm; Moussa Seydi; Guillaume Bado; Ponsiano Ocama; Monique I Andersson; Eugène Messou; Albert Minga; Philippa Easterbrook; Kathryn Anastos; François Dabis; Gilles Wandeler
Journal:  BMC Infect Dis       Date:  2017-11-01       Impact factor: 3.090

6.  The role of endoscopy after upper gastrointestinal bleeding in sub-Saharan Africa: A prospective observational cohort study.

Authors:  Jared R Gallaher; Gift Mulima; Javeria Qureshi; Carol G Shores; Anthony G Charles
Journal:  Malawi Med J       Date:  2020-09       Impact factor: 0.875

7.  Etiology and mode of presentation of chronic liver diseases in India: A multi centric study.

Authors:  Partha S Mukherjee; Sreenivas Vishnubhatla; Deepak N Amarapurkar; Kausik Das; Ajit Sood; Yogesh K Chawla; Chundamannil E Eapen; Prabhakar Boddu; Varghese Thomas; Subodh Varshney; Diamond Sharma Hidangmayum; Pradip Bhaumik; Bhaskar Thakur; Subrat K Acharya; Abhijit Chowdhury
Journal:  PLoS One       Date:  2017-10-26       Impact factor: 3.240

Review 8.  Assessment of risk factors, and racial and ethnic differences in hepatocellular carcinoma.

Authors:  Ramesh P Thylur; Sanjit K Roy; Anju Shrivastava; Thomas A LaVeist; Sharmila Shankar; Rakesh K Srivastava
Journal:  JGH Open       Date:  2020-04-15

9.  Liver function tests and fibrosis scores in a rural population in Africa: a cross-sectional study to estimate the burden of disease and associated risk factors.

Authors:  Geraldine O'Hara; Jolynne Mokaya; Philippa C Matthews; Robert Newton; Jeffrey P Hau; Louise O Downs; Anna L McNaughton; Alex Karabarinde; Gershim Asiki; Janet Seeley
Journal:  BMJ Open       Date:  2020-03-31       Impact factor: 2.692

10.  All coffee types decrease the risk of adverse clinical outcomes in chronic liver disease: a UK Biobank study.

Authors:  Oliver J Kennedy; Jonathan A Fallowfield; Robin Poole; Peter C Hayes; Julie Parkes; Paul J Roderick
Journal:  BMC Public Health       Date:  2021-06-22       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.